EP Wealth Advisors LLC Invests $212,000 in Avanos Medical, Inc. (NYSE:AVNS)

EP Wealth Advisors LLC acquired a new stake in Avanos Medical, Inc. (NYSE:AVNS) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 8,819 shares of the company’s stock, valued at approximately $212,000.

A number of other hedge funds have also recently added to or reduced their stakes in AVNS. Paradice Investment Management LLC raised its stake in shares of Avanos Medical by 5.4% during the 2nd quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company’s stock worth $26,791,000 after buying an additional 69,389 shares in the last quarter. Foundry Partners LLC lifted its holdings in Avanos Medical by 1.1% in the third quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock valued at $3,918,000 after acquiring an additional 1,800 shares during the period. AQR Capital Management LLC boosted its position in shares of Avanos Medical by 21.0% during the 2nd quarter. AQR Capital Management LLC now owns 146,983 shares of the company’s stock worth $2,875,000 after purchasing an additional 25,467 shares in the last quarter. FMR LLC grew its stake in shares of Avanos Medical by 34.6% during the 3rd quarter. FMR LLC now owns 133,844 shares of the company’s stock worth $3,216,000 after purchasing an additional 34,421 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Avanos Medical by 12.0% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 108,470 shares of the company’s stock valued at $2,607,000 after purchasing an additional 11,613 shares in the last quarter. Institutional investors and hedge funds own 95.17% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

Avanos Medical Stock Performance

AVNS opened at $17.97 on Friday. Avanos Medical, Inc. has a 1-year low of $17.39 and a 1-year high of $25.36. The stock has a market cap of $825.90 million, a P/E ratio of 52.85 and a beta of 0.95. The stock’s 50 day simple moving average is $20.27 and its 200 day simple moving average is $21.43. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.